Rick E. Winningham, Director at Jazz Pharmaceuticals plc (JAZZ), sold 11,000 shares at $180.86 ($2.0M) on 2025-11-18, disclosed to the SEC on 2025-11-20.
Open-market sale of $2.0M JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $180.86 | 5,500 | $995K | 50.0% |
| 2 | $180.86 | 5,500 | $995K | 50.0% |
| Total | $180.86 avg | 11,000 | $2.0M | 100% |
| Filing → |
| TBPH | SELL | 2022-12-16 | $560K | — | Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |